Inventor
ZHU YONG-LIANG
US38 patents
⚠️ This page may combine multiple inventors who share the name “ZHU YONG-LIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUPHARMA INC
25 patentsUS10172868B2Jan 8, 2019
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC10 citations92
US9849139B2Dec 26, 2017
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC12 citations92
US9572808B2Feb 21, 2017
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
NEUPHARMA INC13 citations92
US9550770B2Jan 24, 2017
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC15 citations92
US11304957B2Apr 19, 2022
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC4 citations84
US10653701B2May 19, 2020
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC7 citations84
US10544106B2Jan 28, 2020
Certain chemical entities, compositions, and methods
NEUPHARMA INC7 citations84
US9725421B2Aug 8, 2017
Substituted quinoxalines as B-raf kinase inhibitors
NEUPHARMA INC6 citations84
US9688635B2Jun 27, 2017
Certain chemical entities, compositions, and methods
NEUPHARMA INC10 citations84
US9670180B2Jun 6, 2017
Certain chemical entities, compositions, and methods
NEUPHARMA INC9 citations84
US9249110B2Feb 2, 2016
Substituted quinoxalines as B-raf kinase inhibitors
NEUPHARMA INC13 citations84
US9249111B2Feb 2, 2016
Substituted quinoxalines as B-RAF kinase inhibitors
NEUPHARMA INC13 citations84
US11865120B2Jan 9, 2024
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC2 citations73
US11208388B2Dec 28, 2021
Certain chemical entities, compositions, and methods
NEUPHARMA INC2 citations73
US10947201B2Mar 16, 2021
Certain chemical entities, compositions, and methods
NEUPHARMA INC6 citations73
US10561652B2Feb 18, 2020
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
NEUPHARMA INC1 citations73
US10137125B2Nov 27, 2018
Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer
NEUPHARMA INC2 citations73
US10065932B2Sep 4, 2018
Certain chemical entities, compositions, and methods
NEUPHARMA INC3 citations73
US10047059B2Aug 14, 2018
Substituted quinoxalines for inhibiting kinase activity
NEUPHARMA INC3 citations73
US9822081B2Nov 21, 2017
Certain chemical entities, compositions, and methods
NEUPHARMA INC3 citations73
US12403145B2Sep 2, 2025
Substituted quinazolines for inhibiting kinase activity
NEUPHARMA INC0 citations62
US12018002B2Jun 25, 2024
Certain chemical entities, compositions, and methods
NEUPHARMA INC0 citations62
US10457641B2Oct 29, 2019
Certain chemical entities, compositions, and methods
NEUPHARMA INC1 citations62
US10759766B2Sep 1, 2020
Certain chemical entities, compositions, and methods
NEUPHARMA INC0 citations52
US10590106B2Mar 17, 2020
Certain chemical entities, compositions, and methods
NEUPHARMA INC0 citations52
PLEXXIKON INC
3 patentsUS9469640B2Oct 18, 2016
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC44 citations98
US9844539B2Dec 19, 2017
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC20 citations93
US10426760B2Oct 1, 2019
Compounds and methods for kinase modulation, and indications therefor
PLEXXIKON INC6 citations84
QIAN XIANGPING
3 patentsUS9518029B2Dec 13, 2016
Certain chemical entities, compositions, and methods
QIAN XIANGPING10 citations84
US8614211B2Dec 24, 2013
Certain chemical entities, compositions, and methods
QIAN XIANGPING0 citations52
US8691977B2Apr 8, 2014
Certain chemical entities, compositions, and methods
QIAN XIANGPING0 citations42